Abstract
In this secondary paper, the authors continue their investigation into the treatment of the amblyopia with atropine. The Pediatric Eye Disease Investigator Group (PEDIG) is to be commended for bringing good science to the investigation of this subject. This present study investigates the relative influence of age, cause of amblyopia, and the initial depth of amblyopia on the efficacy of atropine. In short, they found that these factors did not have a significant influence. In this study, as well as the primary outcome study,1 the authors concluded that atropine and patching produce improvement of similar magnitude, and that both are appropriate methods of treatment. They suggested that in some cases, “parent, or even child preference, may be the overriding factor in deciding which treatment to prescribe.”
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
